PLEASANTON, Calif., May 3, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2023. Recent Highlights Revenue was $134.3 million for the first quarter, representing a 17% increase over the corresponding period of...
News Ticker
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Clinical Data Manager – Revolution Medicines – Redwood City, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomics and Ecology in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Associate II, Analytical Development, Bioassays – Vir Biotechnology, Inc. – San Francisco, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
